Effects of hypoxia on the expression and activity of cyclooxygenase 2 in fibroblast-like synoviocytes - Interactions with monocyte-derived soluble mediators (Publication with Expression of Concern. See vol. 71, pg. 1376, 2019)

被引:30
作者
Demasi, M [1 ]
Cleland, LG [1 ]
Cook-Johnson, RJ [1 ]
James, MJ [1 ]
机构
[1] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 08期
关键词
D O I
10.1002/art.20429
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective. Rheumatoid synovium is characterized by hyperplasia of fibroblast-like (type B) synoviocytes (FLS), infiltration with mononuclear leukocytes, and tissue hypoxia. Although the latter is well documented, it has received little attention in dissection of the biochemical events that mediate the inflammatory lesion in rheumatoid arthritis (RA). Therefore, this study was designed to assess the effect of hypoxia on FLS responses to the monokine interleukin-1beta (IL-1beta) and to monocyte conditioned medium. Methods. FLS obtained from serial cultures of synovial fluid aspirates were treated with IL-1beta or monocyte conditioned medium, under normoxia and hypoxia. Results. In hypoxia, transcription of cyclooxygenase 2 (COX-2), expression of COX-2 protein, and production of COX-2-derived eicosanoids and matrix metalloproteinase (MMP) activity by FLS were all increased in response to IL-1beta. In contrast to our recent observations concerning monocytes, there was no change in COX-2 message stability and cytosolic phospholipase A(2) activity in the FLS under hypoxia. Treatment of monocyte conditioned medium with an IL-1beta blocking antibody showed that most of the effect of the conditioned medium was attributable to IL-1beta. Conclusion. The findings suggest that hypoxia is an important factor in aggravating the inflammatory lesion in RA, through increased production of COX-2-derived nociceptive eicosanoids and increased release of tissue-damaging MMPs.
引用
收藏
页码:2441 / 2449
页数:9
相关论文
共 48 条
[1]
Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 [J].
Adderley, SR ;
Fitzgerald, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5038-5046
[2]
AKASHI M, 1994, BLOOD, V83, P3182
[3]
Aupperle KR, 1998, AM J PATHOL, V152, P1091
[4]
Barrios-Rodiles M, 1999, J IMMUNOL, V163, P963
[5]
Caughey GE, 2001, J BIOL CHEM, V276, P37839
[6]
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[7]
Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity [J].
Chang, YWE ;
Jakobi, R ;
McGinty, A ;
Foschi, M ;
Dunn, MJ ;
Sorokin, A .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (22) :8571-8579
[8]
Chen V, 1998, BRIT J RHEUMATOL, V37, P148
[9]
The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency [J].
Cok, SJ ;
Morrison, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :23179-23185
[10]
RETRACTED: Effects of hypoxia on monocyte inflammatory mediator production - Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis (Publication with Expression of Concern. See vol. 292, pg. 15993, 2017) (Retracted article. See vol. 293, pg. 20013, 2018) [J].
Demasi, M ;
Cleland, LG ;
Cook-Johnson, RJ ;
Caughey, GE ;
James, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38607-38616